Epigenetics Drives Pharma Innovation - Therapeutics targeting epigenetic mechanisms of disease will change the pharmaceutical marketplace. - BioPharm International

ADVERTISEMENT

Epigenetics Drives Pharma Innovation
Therapeutics targeting epigenetic mechanisms of disease will change the pharmaceutical marketplace.


BioPharm International
Volume 26, Issue 1, pp. 32-33

REFERENCES

1. M.E. Donohoe ME. Results Probl. Cell Differ. 55, 231–45 (2012).

2. K. Banno et al., Biochem. Res. Int. onlline, DOI :10.1155/2012/738274 738274, February, 2012.

3. Y. Boumber and J.P. Issa, Oncology 25 (3), 220–228 (2011).

4. P. Lopez-Serra and M. Esteller, Oncogene 31 (13), 1609–1622 (2012).

5. M. Esteller, N. Eng. J. Med. 358, 1148–1159 (2008).

6. P. Ao et al., Med. Hypotheses 70 (3), 678–684 (2008).

7. S.K. Bolta et al., Breast Cancer Res. Treat. 135 (3), 705–13 (2012).

8. Cai et al., Int. J. Mol. Sci. 12 (7), 4465–4487 (2012).

9. S.B. Baylin and P.A. Jones, Nat. Rev. Cancer 11 (10), 726–734 (2011).

10. M. Tessema et al., Carcinogenesis 30 (7), 1132–1138 (2009).

11. J.M Yingling JM, "The Changing Field of Drug Development," online Jul. 16, 2012. http://ecancer.org/tv/subject/611/1547/video.10 accessed Dec. 13, 2012.

12. P. Cuatrecasas, J. Clin. Invest. 116 (11), 2837–2842 (2006).

13. T. Kubota, K. Miyake, and T. Hirasawa, Clin. Epigenetics 4 (1), 1 (2012).

14. K.J. Morrow, Kalorama Reports, Pub ID: KLI3860511, pg. 160 (2012).


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

NIH Launches Human Safety Study of Ebola Vaccine Candidate
August 29, 2014
Suppliers Seek to Boost Single-Use Technology
August 21, 2014
Bristol-Myers Squibb and Celgene Collaborate on Immunotherapy and Chemotherapy Combination Regimen
August 20, 2014
FDA Warns about Fraudulent Ebola Treatments
August 15, 2014
USP Awards Analytical Research
August 15, 2014
Author Guidelines
Source: BioPharm International,
Click here